carbon monoxide and Coronary Artery Disease
carbon monoxide has been researched along with Coronary Artery Disease in 16 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we investigated the association between acute carbon monoxide (CO) exposure and cardiac autonomic function as measured by heart rate variability (HRV) in subjects with stable coronary artery disease." | 9.10 | Effect of acute carbon monoxide exposure on heart rate variability in patients with coronary artery disease. ( Alm, S; Hartikainen, JE; Pekkanen, J; Tarkiainen, TH; Timonen, KL; Vanninen, EJ, 2003) |
"Carbon monoxide intoxication and smoke inhalation injury can lead to severe disorders, and the current literature has elaborated on the importance of major cardiopulmonary impairment." | 5.72 | Exercise-induced myocardial ischemia presenting as exercise intolerance after carbon monoxide intoxication and smoke inhalation Injury: case report. ( Chou, CL; Hsu, PC; Huang, CC; Hung, SY; Lee, JT; Liu, KF; Wang, YM, 2022) |
" In this study, we investigated the association between acute carbon monoxide (CO) exposure and cardiac autonomic function as measured by heart rate variability (HRV) in subjects with stable coronary artery disease." | 5.10 | Effect of acute carbon monoxide exposure on heart rate variability in patients with coronary artery disease. ( Alm, S; Hartikainen, JE; Pekkanen, J; Tarkiainen, TH; Timonen, KL; Vanninen, EJ, 2003) |
"To address and study the safety concerns with the improved carbon monoxide (CO) rebreathing method for measuring total blood volume in patients with coronary artery disease to implement the use of the methodology in this patient group." | 3.83 | Safety of the CO-Rebreathing Method in Patients with Coronary Artery Disease. ( Aamot, IL; Dalen, H; Karlsen, T; Leinan, IM; Støylen, A, 2016) |
"Carbon monoxide intoxication and smoke inhalation injury can lead to severe disorders, and the current literature has elaborated on the importance of major cardiopulmonary impairment." | 1.72 | Exercise-induced myocardial ischemia presenting as exercise intolerance after carbon monoxide intoxication and smoke inhalation Injury: case report. ( Chou, CL; Hsu, PC; Huang, CC; Hung, SY; Lee, JT; Liu, KF; Wang, YM, 2022) |
"A subgroup of patients with idiopathic pulmonary arterial hypertension (IPAH) has severely reduced diffusing capacity of the lung for carbon monoxide (DLCO) and poor prognosis." | 1.39 | Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. ( Bogaard, HJ; Boonstra, A; de Man, FS; Groepenhoff, H; Grünberg, K; Leter, EM; Nossent, EJ; Trip, P; van den Berk, IA; Vonk-Noordegraaf, A; Westerhof, N, 2013) |
Research
Studies (16)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 4 (25.00) | 29.6817 |
2010's | 9 (56.25) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Wang, YM | 1 |
Huang, CC | 1 |
Liu, KF | 1 |
Chou, CL | 1 |
Lee, JT | 1 |
Hung, SY | 1 |
Hsu, PC | 1 |
Rasch-Halvorsen, Ø | 1 |
Hassel, E | 1 |
Brumpton, BM | 1 |
Jenssen, H | 1 |
Spruit, MA | 1 |
Langhammer, A | 1 |
Steinshamn, S | 1 |
Wang, HL | 1 |
Wang, PC | 1 |
Wu, YW | 1 |
Shyu, KG | 1 |
Chandra, D | 1 |
Gupta, A | 1 |
Fitzpatrick, M | 1 |
Haberlen, SA | 1 |
Neupane, M | 1 |
Leader, JK | 1 |
Kingsley, LA | 1 |
Kleerup, E | 1 |
Budoff, MJ | 1 |
Witt, M | 1 |
Sciurba, FC | 1 |
Post, WS | 1 |
Morris, A | 1 |
Kishimoto, Y | 1 |
Kondo, K | 1 |
Momiyama, Y | 1 |
Trip, P | 1 |
Nossent, EJ | 1 |
de Man, FS | 1 |
van den Berk, IA | 1 |
Boonstra, A | 1 |
Groepenhoff, H | 1 |
Leter, EM | 1 |
Westerhof, N | 1 |
Grünberg, K | 1 |
Bogaard, HJ | 1 |
Vonk-Noordegraaf, A | 1 |
Huston, B | 1 |
Froloff, V | 1 |
Mills, K | 1 |
McGee, M | 1 |
Karlsen, T | 1 |
Leinan, IM | 1 |
Aamot, IL | 1 |
Dalen, H | 1 |
Støylen, A | 1 |
Szturmowicz, M | 1 |
Kacprzak, A | 1 |
Franczuk, M | 1 |
Burakowska, B | 1 |
Kurzyna, M | 1 |
Fijałkowska, A | 1 |
Skoczylas, A | 1 |
Wesołowski, S | 1 |
Kuś, J | 1 |
Torbicki, A | 1 |
Steiger, C | 1 |
Hermann, C | 1 |
Meinel, L | 1 |
Larsen, K | 1 |
Cheng, C | 1 |
Duckers, HJ | 1 |
Tarkiainen, TH | 1 |
Timonen, KL | 1 |
Vanninen, EJ | 1 |
Alm, S | 1 |
Hartikainen, JE | 1 |
Pekkanen, J | 1 |
Grosser, N | 1 |
Schröder, H | 1 |
Dales, R | 1 |
Monahan, K | 1 |
Eshaghian, A | 1 |
Dixon, J | 1 |
Gering, SA | 1 |
Folts, JD | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients[NCT01470274] | 18 participants (Actual) | Observational | 2011-11-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
3 reviews available for carbon monoxide and Coronary Artery Disease
Article | Year |
---|---|
The Protective Role of Heme Oxygenase-1 in Atherosclerotic Diseases.
Topics: Animals; Atherosclerosis; Biliverdine; Carbon Monoxide; Coronary Artery Disease; Heme; Heme Oxygenas | 2019 |
Localized delivery of carbon monoxide.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Animals; Biliverdine; C | 2017 |
Regulation of vulnerable plaque development by the heme oxygenase/carbon monoxide system.
Topics: Animals; Carbon Monoxide; Coronary Artery Disease; Disease Models, Animal; Heme Oxygenase (Decyclizi | 2010 |
Trials
2 trials available for carbon monoxide and Coronary Artery Disease
Article | Year |
---|---|
Effect of acute carbon monoxide exposure on heart rate variability in patients with coronary artery disease.
Topics: Acute Disease; Aged; Air Pollution; Autonomic Nervous System; Carbon Monoxide; Coronary Artery Disea | 2003 |
Ambient carbon monoxide may influence heart rate variability in subjects with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Carbon Monoxide; Comorbidity; | 2004 |
Other Studies
11 other studies available for carbon monoxide and Coronary Artery Disease
Article | Year |
---|---|
Exercise-induced myocardial ischemia presenting as exercise intolerance after carbon monoxide intoxication and smoke inhalation Injury: case report.
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Coronary Artery Disease; Fires; Humans; Male; Myocardial | 2022 |
The association between normal lung function and peak oxygen uptake in patients with exercise intolerance and coronary artery disease.
Topics: Aged; Body Mass Index; Carbon Monoxide; Coronary Artery Disease; Exercise Test; Exercise Tolerance; | 2020 |
[Factors Associated With Successful Smoking Cessation in Male Patients With Coronary Artery Disease at 3 Months After Hospital Discharge].
Topics: Breath Tests; Carbon Monoxide; Coronary Artery Disease; Humans; Logistic Models; Male; Patient Disch | 2017 |
Lung Function, Coronary Artery Disease, and Mortality in HIV.
Topics: Adult; Carbon Monoxide; Case-Control Studies; CD4 Lymphocyte Count; Comorbidity; Coronary Artery Dis | 2019 |
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.
Topics: Adult; Aged; Carbon Monoxide; Coronary Artery Disease; Familial Primary Pulmonary Hypertension; Fema | 2013 |
Carbon monoxide poisoning and death in a large enclosed ventilated area.
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Coronary Artery Disease; Coronary Stenosis; Forensic Pat | 2013 |
Safety of the CO-Rebreathing Method in Patients with Coronary Artery Disease.
Topics: Aged; Blood Gas Analysis; Blood Pressure; Blood Volume; Carbon Monoxide; Coronary Artery Disease; Cr | 2016 |
Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.
Topics: Adolescent; Adult; Age Factors; Aged; Carbon Monoxide; Coronary Artery Disease; Familial Primary Pul | 2016 |
[Therapy with NO donors-antiatherogenic and antioxidant actions].
Topics: Animals; Antioxidants; Arteriosclerosis; Carbon Monoxide; Clinical Trials as Topic; Coronary Artery | 2004 |
An unusual CO-conspirator in a case of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Carbon Monoxide; Carbon Monoxide Poisoning; Coronary Artery Disease; | 2008 |
Exacerbation of acute platelet thrombus formation in stenosed dog coronary arteries with smoke from a non-tobacco-burning cigarette.
Topics: Animals; Blood Platelets; Blood Pressure; Carbon Monoxide; Coronary Artery Disease; Coronary Circula | 1990 |